GERALD MCMAHON, PH.D. - Corporate Board Profile

Oncotelic Therapeutics, Inc.

Filing Date	Source Excerpt
2011-09-22	Currently, the Audit Committee consists of William N. Shiebler (Chairman), Tamar D. Howson and Gerald McMahon... Dr. McMahon was appointed to the Audit Committee on September 2, 2011... Currently, the Compensation Committee consists of William N. Shiebler and Gerald McMahon... Dr. McMahon was appointed to the Compensation Committee on September 2, 2011... No compensation mentioned for Dr. McMahon in the director compensation table.
2012-04-20	GERALD MCMAHON, PH.D. Age: 57 Director Since: 2011 Principal Occupation: Dr. McMahon is Senior Vice President and Oncology Innovative Medicines Unit Leader of Medimmune LLC. ... Audit Committee consists of William D. Schwieterman, Tamar D. Howson and Gerald McMahon (Chairman). ... Compensation Committee consists of William D. Schwieterman, Tamar D. Howson (Chair) and Gerald McMahon. ... Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson and Dr. McMahon. ... Director Compensation Table shows Gerald S. McMahon with total compensation of $26,667.
2013-06-13	The Audit Committee consists of William D. Schwieterman, Tamar D. Howson and Gerald McMahon (Chairman). ... The Compensation Committee consists of William D. Schwieterman, Tamar D. Howson (Chair) and Gerald McMahon. ... The Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson and Dr. McMahon. ... The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2012 to each of our non-employee directors. Gerald McMahon: $80,000.
2014-04-30	The Audit Committee consists of Ms. Howson, Mr. Driscoll and Dr. McMahon (Chairman). The Compensation Committee consists of Ms. Howson (Chair), Mr. Driscoll and Dr. McMahon. The Nominating and Governance Committee consists of Ms. Howson and Drs. Schwieterman (Chairman) and McMahon. The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2013 to each of our non-employee directors. Gerald McMahon: $80,000.
2015-04-17	The Audit Committee consists of Mr. Driscoll (Chairman), Dr. McMahon, and Ms. Howson. Dr. Schwieterman was a member of the Audit Committee in fiscal year 2014 until the appointment of Mr. Driscoll to the Audit Committee in February 2014. During fiscal year 2014, the Audit Committee held five meetings. Our Audit Committee has the authority to retain and terminate the services of our independent registered public accounting firm, reviews our annual financial statements, considers matters relating to accounting policy and internal controls, and reviews the scope of our annual audits. The Board of Directors has adopted a charter for the Audit Committee, which is reviewed and reassessed annually by the Audit Committee. The Compensation Committee consists of Ms. Howson (Chairperson), Mr. Driscoll, and Dr. McMahon. During fiscal year 2014, the Compensation Committee held four meetings. Dr. Schwieterman was a member of the Compensation Committee in fiscal year 2014 until the appointment of Mr. Driscoll to the Compensation Committee in February 2014. Effective on the date of the Annual Meeting, Dr. Schwieterman will replace Dr. McMahon as a member of the Compensation Committee. The Compensation Committee's roles and responsibilities are set forth in the Compensation Committee's written charter, and include making recommendations to the Board of Directors regarding the compensation philosophy and compensation guidelines for our executives, the role and performance of our executive officers, and appropriate compensation levels for our CEO, which are determined without the CEO present, and other executives based on a comparative review of compensation practices of similarly situated businesses. The Compensation Committee also makes recommendations to the Board regarding the design and implementation of our compensation plans and the establishment of criteria and the approval of performance results relative to our incentive plans. The Nominating and Governance Committee consists of Dr. Schwieterman (Chairman), Ms. Howson, and Dr. McMahon. Effective on the date of the Annual Meeting, Dr. McMahon will replace Dr. Schwieterman as the Chairman of the Nominating and Governance Committee. The Nominating and Governance Committee's role and responsibilities are set forth in the Nominating and Governance Committee's written charter and include making recommendations to the full Board as to the size and composition of the Board and making recommendations as to particular nominees to the Board. All members of the Nominating and Governance Committee qualify as independent under the definition promulgated by The NASDAQ Stock Market. The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2014 to each of our non-employee directors. Gerald McMahon: Fees Earned or Paid in Cash ($): 50,000; Stock Awards($): 20,000; Option Awards($): 0; All Other Compensation ($): 0; Total: 70,000.
2016-04-25	Dr. McMahon currently serves as President and Chief Executive Officer of Kolltan Pharmaceuticals, Inc. The Audit Committee consists of Mr. Driscoll (Chairman), Dr. McMahon, and Ms. Howson. The Compensation Committee consists of Ms. Howson (Chairperson), Mr. Driscoll, and Dr. McMahon. The Nominating and Governance Committee consists of Mr. Driscoll, Ms. Howson, and Dr. McMahon (Chairman).